title: Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety.
authors.affiliation: Department of Medicine, Queen Mary Hospital, Pokfulam Road, Pok Fu Lam, Hong Kong.
authors.forename: Thomas S Y
authors.initials: TS
authors.lastname: Chan
authors.affiliation: Department of Diagnostic Radiology, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
authors.forename: Pek-Lan
authors.initials: PL
authors.lastname: Khong
authors.affiliation: Department of Medicine, Queen Mary Hospital, Pokfulam Road, Pok Fu Lam, Hong Kong. ylkwong@hkucc.hku.hk.
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors / Q000276:immunology; D000079963:Brentuximab Vedotin; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage; D008172:Lung Diseases, Fungal / Q000000981:diagnostic imaging / Q000209:etiology; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy* / Q000628:therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000276:immunology; D000072078:Positron Emission Tomography Computed Tomography; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D014184:Transplantation, Homologous
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; C423236:CD274 protein, human; D018796:Immunoconjugates; D009363:Neoplasm Proteins; D000079963:Brentuximab Vedotin; C582435:pembrolizumab